Clinical Trials
25 trialsSub-lobectomy vs Lobectomy in IIA-IIIB NSCLC After Neoadjuvant IO+Chemo
Guangdong Provincial People's Hospital
TRIPL
Montefiore Medical Center
The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer
Fudan University
Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC）
Tongji Hospital
The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer
Shanghai Chest Hospital
A Prospective Phase II Clinical Study of Immunotherapy Combined With Chemotherapy for Stage III Unresectable Non-small Cell Lung Cancer
Jiangsu Cancer Institute & Hospital
LUNG-05
University of Illinois at Chicago
TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy
Tianjin Medical University Cancer Institute and Hospital
Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC
Peking Union Medical College
Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient
Zibo Municipal Hospital
WU-KONG20
Tang-Du Hospital
Tislelizumab Combined With sCRT in Stage IIIB/C-IV Non-Squamous Non-Small Cell Lung Cancer：A Prospective, Single-Arm, Phase II Study
Zibo Municipal Hospital
iRelate
Amsterdam UMC, location VUmc
Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC
Anhui Provincial Cancer Hospital
KEAPnes
Regina Elena Cancer Institute
Neoadjuvant/Adjuvant Cadonilimab Plus Chemotherapy in Patients With Resectable PD-L1 Negative NSCLC
Sichuan Cancer Hospital and Research Institute
A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
PRIME_LUNG
Peter MacCallum Cancer Centre, Australia
EGFR
National Cancer Center, China
ACCLAIM
Shanghai Pulmonary Hospital, Shanghai, China
A Real-World Study of Atezolizumab in Combination With Platinum-Based Doublet Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-IIIB NSCLC
Hunan Province Tumor Hospital
99mTc-H7ND SPECT/CT Imaging in NSCLC
First Affiliated Hospital Xi'an Jiaotong University
Seagull
The First Affiliated Hospital of Zhengzhou University
Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.
University Hospital, Strasbourg, France
Novel Approach to Radiotherapy in Locally Advanced Lung Cancer Concomitant Navelbine®
Odense University Hospital